Skip to search formSkip to main contentSkip to account menu

canagliflozin anhydrous

Known as: 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene - T777973, Anhydrous Canagliflozin, Canagliflozin, Anhydrous 
The anhydrous form of canagliflozin, a C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Canagliflozin (Invokana, JNJ-28431754) is an orally bioavailable and selective SGLT2 (subtype 2 sodium-glucose transport protein… 
2017
2017
The effect of different doses of vitamin D for prevention of wintertime respiratory tract infections (RTI) in preschool children… 
Review
2016
Review
2016
The prevalence of type 2 diabetes is rising, and in 2015 more than 5% of adults in the UK were affected by this condition.1,2… 
2015
2015
Canagliflozin, a sodium glucose co‐transporter 2 inhibitor, improves indices of β‐cell function estimated based on circulating C… 
2015
2015
A composition of amorphous Canagliflozin and medicinal adjuvants and a preparation method thereof are disclosed, the composition… 
2014
2014
6-Deoxylated Canagliflozin,4-( 6-deoxy-β-D-glucopyranosyl)-2-[5-( 4-fluorophenyl) thiophen-2-yl]-1-toluene( 8),a novel SGLT2… 
2013
2013
133 As we sit down to write this Editorial, the last issue of the Journal of the American Society of Nephrology stands in front…